Humedix Co., Ltd. (KOSDAQ:200670)
 50,300
 -200 (-0.40%)
  Oct 31, 2025, 3:30 PM KST
Humedix Market Cap
Humedix has a market cap or net worth of 521.17 billion as of October 30, 2025. Its market cap has increased by 50.56% in one year.
Market Cap 
 521.17B
Enterprise Value 
 n/a
Revenue 
 110.99B
Ranking 
 n/a
PE Ratio 
 52.39
Stock Price 
50,300.00
Market Cap Chart
Since December 26, 2014, Humedix's market cap has increased from 223.01B to 521.17B, an increase of 133.70%. That is a compound annual growth rate of 8.14%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 521.17B | 19.66% | 
| Dec 30, 2024 | 435.54B | 24.67% | 
| Dec 28, 2023 | 349.36B | 38.28% | 
| Dec 29, 2022 | 252.65B | 12.18% | 
| Dec 30, 2021 | 225.21B | -0.11% | 
| Dec 30, 2020 | 225.47B | 2.25% | 
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro | 
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro | 
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Samsung Biologics | 86.90T | 
| Celltrion | 38.57T | 
| ALTEOGEN | 25.24T | 
| SK Biopharmaceuticals | 8.88T | 
| Yuhan | 8.68T | 
| HLB Co., Ltd. | 6.43T | 
| Peptron | 6.13T | 
| PharmaResearch | 5.65T |